(Q80413320)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541384%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Serum uric acid, the endothelium and hypertension: an association revisited (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541384%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Reynolds T

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541384%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

31 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541384%20AND%20SRC:MED&resulttype=core&format=json

Journal of Human Hypertension

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541384%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541384%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541384%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

591-593

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541384%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1002239

31 December 2019

exact match

0 references

cites work

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Ambulatory blood pressure and mortality: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Socioeconomic status is associated with nocturnal blood pressure dipping.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Ambulatory blood pressure variability and brachial-ankle pulse wave velocity in untreated hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Ambulatory blood pressure, asymptomatic cerebrovascular damage and cognitive function in essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Impact of gender on 24-h ambulatory blood pressure and target organ damage.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Uric acid and the development of hypertension: the normative aging study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Serum uric acid: a risk factor and a target for treatment?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Serum uric acid is a determinant of metabolic syndrome in a population-based study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Serum uric acid is associated with microvascular function in hypertensive individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Status of endothelial dependent vasodilation in patients with hyperuricemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Hormonal and cytokine effects of uric acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Is the nocturnal fall in blood pressure reduced in essential hypertensive patients with metabolic syndrome?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Metabolic syndrome as a predictor of non-dipping hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002239

7 January 2021